428 related articles for article (PubMed ID: 33957948)
1. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression.
Jin J; Li Y; Zhao Q; Chen Y; Fu S; Wu J
Cell Commun Signal; 2021 May; 19(1):50. PubMed ID: 33957948
[TBL] [Abstract][Full Text] [Related]
2. The role of STAT3 in leading the crosstalk between human cancers and the immune system.
Wang Y; Shen Y; Wang S; Shen Q; Zhou X
Cancer Lett; 2018 Feb; 415():117-128. PubMed ID: 29222039
[TBL] [Abstract][Full Text] [Related]
3. STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context.
Segatto I; Baldassarre G; Belletti B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231553
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.
Jones LM; Broz ML; Ranger JJ; Ozcelik J; Ahn R; Zuo D; Ursini-Siegel J; Hallett MT; Krummel M; Muller WJ
Cancer Res; 2016 Mar; 76(6):1416-28. PubMed ID: 26719528
[TBL] [Abstract][Full Text] [Related]
6. Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.
Jenkins S; Wesolowski R; Gatti-Mays ME
Curr Oncol Rep; 2021 Mar; 23(5):55. PubMed ID: 33755828
[TBL] [Abstract][Full Text] [Related]
7. Targeting STAT3 in Cancer Immunotherapy.
Zou S; Tong Q; Liu B; Huang W; Tian Y; Fu X
Mol Cancer; 2020 Sep; 19(1):145. PubMed ID: 32972405
[TBL] [Abstract][Full Text] [Related]
8. Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance.
Hashimoto S; Hashimoto A; Muromoto R; Kitai Y; Oritani K; Matsuda T
Cells; 2022 Aug; 11(16):. PubMed ID: 36010693
[TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol-induced EndMT acts
Jiao K; Zhen J; Wu M; Teng M; Yang K; Zhou Q; Hu C; Zhou M; Li Y; Li Z
Cancer Biol Med; 2020 Feb; 17(1):88-100. PubMed ID: 32296578
[No Abstract] [Full Text] [Related]
10. Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.
Tuccitto A; Shahaj E; Vergani E; Ferro S; Huber V; Rodolfo M; Castelli C; Rivoltini L; Vallacchi V
Virchows Arch; 2019 Apr; 474(4):407-420. PubMed ID: 30374798
[TBL] [Abstract][Full Text] [Related]
11. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
12. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Yu H; Kortylewski M; Pardoll D
Nat Rev Immunol; 2007 Jan; 7(1):41-51. PubMed ID: 17186030
[TBL] [Abstract][Full Text] [Related]
13. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
Piperi C; Papavassiliou KA; Papavassiliou AG
Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Visfatin-Promoted Malignant Behavior in Breast Cancer Is Mediated Through c-Abl and STAT3 Activation.
Hung AC; Lo S; Hou MF; Lee YC; Tsai CH; Chen YY; Liu W; Su YH; Lo YH; Wang CH; Wu SC; Hsieh YC; Hu SC; Tai MH; Wang YM; Yuan SS
Clin Cancer Res; 2016 Sep; 22(17):4478-90. PubMed ID: 27036136
[TBL] [Abstract][Full Text] [Related]
15. Exposure of tumor-associated macrophages to apoptotic MCF-7 cells promotes breast cancer growth and metastasis.
Zhou N; Zhang Y; Zhang X; Lei Z; Hu R; Li H; Mao Y; Wang X; Irwin DM; Niu G; Tan H
Int J Mol Sci; 2015 May; 16(6):11966-82. PubMed ID: 26016502
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
Akinsipe T; Mohamedelhassan R; Akinpelu A; Pondugula SR; Mistriotis P; Avila LA; Suryawanshi A
Front Immunol; 2024; 15():1302587. PubMed ID: 38533507
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
18. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
19. Highlighted STAT3 as a potential drug target for cancer therapy.
Lee H; Jeong AJ; Ye SK
BMB Rep; 2019 Jul; 52(7):415-423. PubMed ID: 31186087
[TBL] [Abstract][Full Text] [Related]
20. The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.
Khan MW; Saadalla A; Ewida AH; Al-Katranji K; Al-Saoudi G; Giaccone ZT; Gounari F; Zhang M; Frank DA; Khazaie K
Cancer Immunol Immunother; 2018 Jan; 67(1):13-23. PubMed ID: 28875329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
